The Division of Hematology/Oncology at IU School of Medicine brings together nationally recognized clinicians, researchers and educators committed to advancing the prevention, diagnosis and treatment of cancer and blood disorders. Under the leadership of Trisha Wise-Draper, MD, PhD, the division delivers exceptional patient care, drives innovative research and trains the next generation of physicians and scientists while improving outcomes and expanding access to leading-edge therapies.
Looking for Patient Care?
Our Values
The Division of Hematology/Oncology is committed to a culture of support and acceptance that respects all faculty, staff and learners and celebrates their backgrounds. Excellence in patient care, research and education begins with an emphasis on the mental and physical health of our workforce.
Research
Research within this division is led by world-renowned faculty members developing innovative protocols, novel treatments and new knowledge to expand the understanding of hematology and oncology.
Clinical Care
Services provided by faculty oncologists include treatment and management of bladder, breast, head and neck, kidney, lung, testicular, thyroid, pancreatic, prostate and salivary gland cancers; cardio-oncology; leukemia; and lymphoma.
Education
Prepare for a career in academic medicine, research and clinical excellence through our combined three-year Hematology/Oncology Fellowship program.
In the News
Study sheds light on relationship between triple-negative breast cancer cells, immune systems
Reza Shahbazi, PhD, and his research team found that triple-negative breast cancer cells release tiny particles called exosomes that can enter T cells and reprogram how they function.
Department of Medicine names new director of Division of Hematology/Oncology
Trisha Wise-Draper is an accomplished physician-scientist, specializing in the care of cancers in the head and neck and experimental therapeutics.